Successful collaboration between FORMAC PHARMACEUTICALS NV and FLAMAC,a division of SIM
“This high-throughput system represents a very important step for FORMAC” says Jan Rosier, FORMAC’s CEO ,“Together with the recent announcement of the collaboration with W.R. GRACE, this milestone will enable the company to position itself as a fully integrated silica-based drug development organization”.
Flamac is a research centre in high-throughput methods which supports the chemical and materials industry. It offers its services in either collaborative or multi-disciplinary government sponsored research projects as well as via bilateral contract research. Flamac is a division of the Strategic Initiative Materials (SIM). SIM is subsidised by the Flemish Government. Its mission is to enhance strategic collaboration between knowledge institutes and the materials industry in Flanders.
“Flamac and SIM are extremely happy to be working with FORMAC Pharmaceuticals. This project has allowed Flamac to further develop and enhance its expertise in high-throughput technologies as well as allowing it to expand its portfolio of industrial partners,” says Johan Paul, manager at Flamac, a division of SIM.